Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2019-12-04 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
第四届董事会第二次会议决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of resolutions passed at the company's fourth board of directors' second meeting. It includes details about changes in the company's business scope, a joint venture investment, and the scheduling of a shareholders' meeting. The document contains voting results for these resolutions. It does not contain financial statements or detailed financial data, nor is it a full report. It is primarily a formal announcement of board decisions and voting outcomes. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1717 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is DVA with high confidence.
2019-12-04 Chinese
关于召开2019年第七次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2019 seventh extraordinary general meeting of shareholders for 瑞康医药集团股份有限公司. It includes information about the meeting time, location, voting procedures (both onsite and online), eligibility to attend, agenda items, and proxy authorization. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement and invitation to shareholders to participate in the meeting and vote on specific proposals. The document length is under 5,000 characters and it primarily serves as a meeting notice and proxy solicitation. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI).
2019-12-04 Chinese
第四届监事会第二次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of a resolution passed at the second meeting of the fourth Supervisory Board of Ruikang Pharmaceutical Group Co., Ltd. It details the approval of an agenda item to increase the business scope and amend the company's articles of association. The document includes voting results and states that the proposal will be submitted to the company's 7th extraordinary general meeting for approval. The content is about board/management decisions and changes related to company governance and business scope, not a full report or financial statement. The document length is short (1134 characters) and it is an announcement of a board meeting resolution rather than a full management report or annual report. Therefore, the appropriate classification is Board/Management Information (MANG).
2019-12-04 Chinese
关于与杭州奋华投资合伙企业（有限合伙）合资设立公司暨对外投资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 瑞康医药集团股份有限公司 regarding a joint investment with 杭州奋华投资合伙企业 to establish a new company. It details the investment amount, shareholder structure, cooperation agreement, and risk disclosures. The document is a formal public announcement about a capital investment and formation of a joint venture company, including board resolutions and investment agreements. It does not contain financial statements, audit information, earnings data, or regulatory certifications. It is not a report but an announcement of a financing/investment activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 4011 characters, which is consistent with an announcement rather than a full report.
2019-12-04 Chinese
关于股份回购的进展公告
Transaction in Own Shares Classification · 95% confidence The document is titled as an announcement regarding the progress of a share repurchase (股份回购的进展公告). It details the number of shares repurchased, prices, total amount paid, and references prior approvals and announcements related to the share buyback plan. The document length is short (987 characters) and it is clearly an update on the company's share repurchase activity, not a full financial report or earnings release. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares. There is no indication that this is a full financial report, audit, or regulatory filing. Therefore, the correct classification is POS with high confidence.
2019-12-03 Chinese
关于实际控制人部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the release of a portion of pledged shares by its actual controller. It details the number of shares released from pledge, the pledge start and release dates, and the current status of pledged shares held by major shareholders. The document includes tables with shareholding and pledge details and states there is no risk of forced liquidation or change in control. There is no financial statement, earnings data, or management discussion. The document is short (1549 characters) and is an announcement about share pledge status, not a financial report or detailed filing. This fits the category of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related shareholding events such as pledge releases.
2019-11-25 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.